Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2006 | |
| Sales | 3,506 | 3,708 | 2,334 | 0 | 0 |
| Cost of Goods | 3,506 | 3,708 | 1,285 | N/A | N/A |
| Gross Profit | N/A | N/A | 1,049 | N/A | N/A |
| Operating Expenses | 39,724 | 30,485 | 19,045 | 9,035 | 0 |
| Operating Income | -39,218 | -29,777 | -17,711 | -9,035 | N/A |
| Other Income | -260 | 56 | 225 | 448 | 0 |
| Pre-tax Income | -39,478 | -29,721 | -17,486 | -8,587 | 0 |
| Income Tax | 776 | 425 | 306 | 286 | N/A |
| Net Income Continuous | -40,254 | -30,146 | -17,792 | -8,873 | N/A |
| Net Income | $-40,254 | $-30,146 | $-17,792 | $-8,873 | $N/A |
| EPS Basic Total Ops | -2.80 | -3.06 | -3.57 | -1.80 | N/A |
| EPS Basic Continuous Ops | -2.80 | -3.06 | -3.57 | -1.80 | N/A |
| EPS Diluted Total Ops | -2.80 | -3.06 | -3.57 | -1.80 | N/A |
| EPS Diluted Continuous Ops | -2.80 | -3.06 | -3.57 | -1.80 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.80 | -3.06 | N/A | N/A | N/A |
| EBITDA(a) | $-39,050 | $-29,595 | $-17,561 | $-8,986 | $N/A |